Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-11-20

Clinical Trial Update: Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease [NA]

View source ↗

Summary

A clinical trial evaluating the effects of indobufen and aspirin on platelet aggregation and long-term prognosis in stable coronary heart disease has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Indobufen (indobufen)

Snippet

Sponsor: Henan Institute of Cardiovascular Epidemiology | Conditions: Stable Coronary Heart Disease | NA | Status: WITHDRAWN